Protolabs Reports Financial Results for the Second Quarter of 2025

7/31/25 6:00:00 AM ET

$PRLB

Metal Fabrications

Industrials

Get the next $PRLB alert in real time by email

Record Quarterly Revenue of $135.1 Million, a 7.5% increase Year-Over-Year

GAAP Earnings Per Share of $0.18, Non-GAAP Earnings Per Share of $0.41

Proto Labs, Inc. ("Protolabs" or the "Company") (NYSE:PRLB), the world's leading provider of digital manufacturing services, today announced financial results for the second quarter ended June 30, 2025.

Second Quarter 2025 Financial Highlights:

Revenue was a record $135.1 million, a 7.5% increase compared to revenue of $125.6 million in the second quarter of 2024.
Revenue fulfilled through digital factories was $105.8 million, a 4.8% increase year-over-year.
Revenue fulfilled through the Protolabs Network was $29.3 million, an 18.6% increase year-over-year.
Net income was $4.4 million, or $0.18 per diluted share, compared to $4.5 million, or $0.18 per diluted share, in the second quarter of 2024.
Non-GAAP net income was $10.0 million, or $0.41 per diluted share, compared to $9.5 million, or $0.38 per diluted share, in the second quarter of 2024. See "Non-GAAP Financial Measures" below.

"Protolabs generated record quarterly revenue in the second quarter, demonstrating the value we provide to customers and reinforcing our ability to execute in a dynamic and uncertain environment," commented President and Chief Executive Officer Suresh Krishna. "Our priorities remain as follows: drive growth in our key performance indicators, expand production capabilities, and reinforce our core prototyping offer. I am pleased with the progress our employees have made through the first half of the year, and I am confident we have the right foundation, team, and strategy in place to drive sustainable growth while maintaining industry-leading profitability and cash flow generation."

Dan Schumacher, Chief Financial Officer, added: "Our strong revenue in the second quarter was driven by growth through both Factory and Network fulfillment. Non-GAAP EPS increased both sequentially and year-over-year, reflecting the strength of our profitable business model. We will continue to invest in growth, drive innovation, execute for our customers, and deliver long-term value to our shareholders."

Additional Second Quarter 2025 Highlights:

Customer contact information
- Protolabs served 21,775 customer contacts during the quarter.
- Revenue per customer contact increased 10.9% year-over-year to $6,203.
EBITDA was $14.1 million. See "Non-GAAP Financial Measures" below.
Adjusted EBITDA was $19.7 million, or 14.6% of revenue, compared to $19.3 million, or 15.4% of revenue, in the second quarter of 2024. See "Non-GAAP Financial Measures" below.
Cash and investments balance was $123.2 million as of June 30, 2025.

Third Quarter 2025 Outlook

In the third quarter of 2025, the Company expects to generate revenue between $130.0 million and $138.0 million.

The Company expects third quarter 2025 diluted net income per share between $0.17 and $0.25, and non-GAAP diluted net income per share between $0.35 and $0.43. See "Non-GAAP Financial Measures" below.

Non-GAAP Financial Measures

The Company has included non-GAAP revenue growth by region and by service line that excludes the impact of changes in foreign currency exchange rates (collectively, "non-GAAP revenue growth"). Management believes these metrics, when viewed in conjunction with the comparable GAAP metrics, are useful in evaluating the underlying business trends and ongoing operating performance of the Company.

The Company has included earnings before interest, taxes, depreciation and amortization ("EBITDA") and EBITDA, adjusted for stock-based compensation expense, unrealized (gain) loss on foreign currency, CEO transition costs and costs related to exit and disposal activities (collectively, "Adjusted EBITDA"), in this press release to provide investors with additional information regarding the Company's financial results. The Company has also included earnings before interest, taxes, depreciation and amortization margin ("EBITDA margin") and EBITDA margin, adjusted for stock-based compensation expense, unrealized (gain) loss on foreign currency, CEO transition costs and costs related to exit and disposal activities (collectively, "Adjusted EBITDA margin"), in this press release to provide investors with additional information regarding the Company's financial results.

The Company has included non-GAAP gross margin, adjusted for stock-based compensation expense and amortization expense, in this press release to provide investors with additional information regarding the Company's financial results.

The Company has included non-GAAP operating margin, adjusted for stock-based compensation expense, amortization expense, CEO transition costs and costs related to exit and disposal activities (collectively, "non-GAAP operating margin"), in this press release to provide investors with additional information regarding the Company's financial results.

The Company has included non-GAAP net income and non-GAAP net income per share, in each case, adjusted for stock-based compensation expense, amortization expense, unrealized (gain) loss on foreign currency, CEO transition costs and costs related to exit and disposal activities (collectively, "non-GAAP net income"), in this press release to provide investors with additional information regarding the Company's financial results.

The Company has provided below reconciliations of GAAP to non-GAAP net income, non-GAAP net income per share, non-GAAP gross margin, non-GAAP operating margin, non-GAAP revenue growth by region and by service line, and Adjusted EBITDA and Adjusted EBITDA margin, the most directly comparable measures calculated and presented in accordance with GAAP. These non-GAAP measures are used by the Company's management and board of directors to understand and evaluate operating performance and trends, provide useful measures for period-to-period comparisons of the Company's business, and in determining executive and senior management incentive compensation. Accordingly, the Company believes that these non-GAAP measures provide useful information to investors and others in understanding and evaluating operating results in the same manner as our management and board of directors. These non-GAAP financial measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP. These non-GAAP financial measures exclude significant expenses and income that are required by GAAP to be recorded in our condensed consolidated financial statements and are subject to inherent limitations. Investors should review the reconciliations of non-GAAP financial measures to the comparable GAAP financial measures that are included in this press release.

Conference Call

The Company has scheduled a conference call to discuss its second quarter 2025 financial results and third quarter 2025 outlook today, July 31, 2025 at 8:30 a.m. EDT. To access the call in the U.S. please dial 877-709-8150 or outside the U.S. dial 201-689-8354 at least five minutes prior to the 8:30 a.m. EDT start time. No participant code is required. A simultaneous webcast of the call and accompanying presentation will be available via the investor relations section of the Protolabs website and the following link: https://edge.media-server.com/mmc/p/mp2aa5du/. A replay will be available for 14 days following the call on the investor relations section of the Protolabs website.

About Protolabs

Protolabs is the fastest and most comprehensive manufacturing service from prototyping to production. Our digital factories produce low-volume parts in days while Protolabs Network unlocks advanced capabilities and volume pricing through its highly vetted manufacturing partners. The result? One digital manufacturing source for product developers, engineers, and supply chain teams across the globe. See what's next at protolabs.com.

Forward-Looking Statements

Statements contained in this press release regarding matters that are not historical or current facts are "forward-looking statements" within the meaning of The Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties and other factors which may cause the results of Protolabs to be materially different than those expressed or implied in such statements. Certain of these risk factors and others are described in the "Risk Factors" section within reports filed with the SEC. Other unknown or unpredictable factors also could have material adverse effects on Protolabs' future results. The forward-looking statements included in this press release are made only as of the date hereof. Protolabs cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, Protolabs expressly disclaims any intent or obligation to update any forward-looking statements to reflect subsequent events or circumstances.


Proto Labs, Inc.
Condensed Consolidated Balance Sheets
(In thousands)


	June 30, 2025		December 31, 2024
	(Unaudited)
Assets
Current assets
Cash and cash equivalents	$	90,382	$	89,071
Short-term marketable securities		12,804		14,019
Accounts receivable, net		78,011		66,504
Inventory		13,169		12,305
Income taxes receivable		1,155		2,906
Prepaid expenses and other current assets		9,985		10,049
Total current assets		205,506		194,854

Property and equipment, net		215,777		227,263
Goodwill		273,991		273,991
Other intangible assets, net		20,500		21,422
Long-term marketable securities		20,037		17,773
Operating lease assets		2,308		2,993
Finance lease assets		558		692
Other long-term assets		4,575		4,524
Total assets	$	743,252	$	743,512

Liabilities and shareholders' equity
Current liabilities
Accounts payable	$	15,583	$	15,504
Accrued compensation		19,435		16,550
Accrued liabilities and other		25,846		19,621
Current operating lease liabilities		984		1,287
Current finance lease liabilities		316		309
Total current liabilities		62,164		53,271

Long-term operating lease liabilities		1,402		1,633
Long-term finance lease liabilities		127		287
Long-term deferred tax liabilities		9,737		13,565
Other long-term liabilities		5,115		4,605

Shareholders' equity		664,707		670,151
Total liabilities and shareholders' equity	$	743,252	$	743,512


Proto Labs, Inc.
Condensed Consolidated Statements of Operations
(In thousands, except share and per share amounts)
(Unaudited)


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
Revenue
Injection Molding	$	47,415	$	49,080	$	96,138	$	101,743
CNC Machining		61,945		51,239		114,788		101,171
3D Printing		21,215		21,281		41,409		42,863
Sheet Metal		4,303		3,922		8,514		7,475
Other Revenue		185		109		419		269
Total Revenue		135,063		125,631		261,268		253,521

Cost of revenue		75,289		69,085		145,796		139,508
Gross profit		59,774		56,546		115,472		114,013

Operating expenses
Marketing and sales		24,731		23,291		48,480		46,451
Research and development		11,173		10,661		21,782		21,828
General and administrative		18,752		16,595		35,600		32,908
Costs related to exit and disposal activities		149		—		110		—
Total operating expenses		54,805		50,547		105,972		101,187
Income from operations		4,969		5,999		9,500		12,826
Other income, net		1,705		1,361		3,159		2,260
Income before income taxes		6,674		7,360		12,659		15,086
Provision for income taxes		2,247		2,820		4,633		5,278
Net income	$	4,427	$	4,540	$	8,026	$	9,808

Net income per share:
Basic	$	0.19	$	0.18	$	0.33	$	0.39
Diluted	$	0.18	$	0.18	$	0.33	$	0.38

Shares used to compute net income per share:
Basic		23,900,390		25,313,036		24,018,119		25,473,937
Diluted		24,101,592		25,372,972		24,291,246		25,573,344


Proto Labs, Inc.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)


	Six Months Ended June 30,
	2025			2024
Operating activities
Net income	$	8,026		$	9,808
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		17,264			18,075
Stock-based compensation expense		8,251			8,520
Deferred taxes		(3,985	)		(4,144	)
Interest on finance lease obligations		11			18
Impairments related to exit and closure of facilities		448			—
Gain on disposal of property and equipment		—			(20	)
Other		(82	)		64
Changes in operating assets and liabilities		(970	)		3,460
Net cash provided by operating activities		28,963			35,781

Investing activities
Purchases of property, equipment and other capital assets		(2,730	)		(6,784	)
Proceeds from sales of property, equipment and other capital assets		—			30
Purchases of marketable securities		(11,052	)		—
Proceeds from call redemptions and maturities of marketable securities		10,230			10,419
Net cash (used in) provided by investing activities		(3,552	)		3,665

Financing activities
Proceeds from issuance of common stock from equity plans		2,081			2,094
Purchases of shares withheld for tax obligations		(3,117	)		(1,920	)
Repurchases of common stock		(23,980	)		(26,940	)
Principal repayments of finance lease obligations		(153	)		(146	)
Net cash used in financing activities		(25,169	)		(26,912	)
Effect of exchange rate changes on cash and cash equivalents		1,069			(175	)
Net increase in cash and cash equivalents		1,311			12,359
Cash and cash equivalents, beginning of period		89,071			83,790
Cash and cash equivalents, end of period	$	90,382		$	96,149


Proto Labs, Inc.
Reconciliation of GAAP to Non-GAAP Net Income and Non-GAAP Net Income per Share
(In thousands, except share and per share amounts)
(Unaudited)


	Three Months Ended June 30,						Six Months Ended June 30,
	2025			2024			2025			2024
Non-GAAP net income, adjusted for stock-based compensation expense, amortization expense, unrealized (gain) loss on foreign currency, CEO transition costs and costs related to exit and disposal activities
GAAP net income	$	4,427		$	4,540		$	8,026		$	9,808
Add back:
Stock-based compensation expense		4,259			4,244			8,251			8,520
Amortization expense		927			921			1,835			1,908
Unrealized (gain) loss on foreign currency		(179	)		(88	)		(314	)		149
CEO transition costs		1,362			—			1,362			—
Costs related to exit and disposal activities		149			—			110			—
Total adjustments ¹		6,518			5,077			11,244			10,577
Income tax benefits on adjustments ²		(958	)		(85	)		(1,200	)		(439	)
Non-GAAP net income	$	9,987		$	9,532		$	18,070		$	19,946


Non-GAAP net income per share:
Basic	$	0.42		$	0.38		$	0.75		$	0.78
Diluted	$	0.41		$	0.38		$	0.74		$	0.78

Shares used to compute non-GAAP net income per share:
Basic		23,900,390			25,313,036			24,018,119			25,473,937
Diluted		24,101,592			25,372,972			24,291,246			25,573,344

Stock-based compensation expense, amortization expense, unrealized (gain) loss on foreign currency, CEO transition costs and costs related to exit and disposal activities were included in the following GAAP consolidated statement of operations categories:

	Three Months Ended June 30,						Six Months Ended June 30,
	2025			2024			2025			2024

Cost of revenue	$	767		$	810		$	1,569		$	1,611

Marketing and sales		808			819			1,586			1,652
Research and development		735			667			1,360			1,359
General and administrative		4,238			2,869			6,933			5,806
Costs related to exit and disposal activities		149			—			110			—
Total operating expenses		5,930			4,355			9,989			8,817

Other income, net		(179	)		(88	)		(314	)		149
Total adjustments	$	6,518		$	5,077		$	11,244		$	10,577

For the three and six months ended June 30, 2025 and 2024, income tax effects were calculated using the effective tax rate for the relevant jurisdictions. The Company's non-GAAP tax rates differ from its GAAP tax rates due primarily to the mix of activity incurred in domestic and foreign tax jurisdictions and removing effective tax rate benefits from stock-based compensation activity in the respective period.


Proto Labs, Inc.
Reconciliation of GAAP to Non-GAAP Gross Margin
(In thousands)
(Unaudited)


	Three Months Ended June 30,						Six Months Ended June 30,
	2025			2024			2025			2024
Revenue	$	135,063		$	125,631		$	261,268		$	253,521
Gross profit		59,774			56,546			115,472			114,013
GAAP gross margin		44.3	%		45.0	%		44.2	%		45.0	%
Add back:
Stock-based compensation expense		424			468			884			927
Amortization expense		343			342			685			684
Total adjustments		767			810			1,569			1,611
Non-GAAP gross profit	$	60,541		$	57,356		$	117,041		$	115,624
Non-GAAP gross margin		44.8	%		45.7	%		44.8	%		45.6	%


Proto Labs, Inc.
Reconciliation of GAAP to Non-GAAP Operating Margin
(In thousands)
(Unaudited)


	Three Months Ended June 30,						Six Months Ended June 30,
	2025			2024			2025			2024
Revenue	$	135,063		$	125,631		$	261,268		$	253,521
Income from operations		4,969			5,999			9,500			12,826
GAAP operating margin		3.7	%		4.8	%		3.6	%		5.1	%
Add back:
Stock-based compensation expense		4,259			4,244			8,251			8,520
Amortization expense		927			921			1,835			1,908
CEO transition costs		1,362			—			1,362			—
Costs related to exit and disposal activities		149			—			110			—
Total adjustments		6,697			5,165			11,558			10,428
Non-GAAP income from operations	$	11,666		$	11,164		$	21,058		$	23,254
Non-GAAP operating margin		8.6	%		8.9	%		8.1	%		9.2	%


Proto Labs, Inc.
Reconciliation of GAAP Net Income to EBITDA and Adjusted EBITDA
(In thousands)
(Unaudited)


	Three Months Ended June 30,						Six Months Ended June 30,
	2025			2024			2025			2024
Revenue	$	135,063		$	125,631		$	261,268		$	253,521
GAAP net income		4,427			4,540			8,026			9,808
GAAP net income margin		3.3	%		3.6	%		3.1	%		3.9	%
Add back:
Amortization expense	$	927		$	921		$	1,835		$	1,908
Depreciation expense		7,643			8,051			15,429			16,167
Interest income, net		(1,143	)		(1,149	)		(2,251	)		(2,261	)
Provision for income taxes		2,247			2,820			4,633			5,278
EBITDA		14,101			15,183			27,672			30,900
EBITDA Margin		10.4	%		12.1	%		10.6	%		12.2	%
Add back:
Stock-based compensation expense		4,259			4,244			8,251			8,520
Unrealized (gain) loss on foreign currency		(179	)		(88	)		(314	)		149
CEO transition costs		1,362			—			1,362			—
Costs related to exit and disposal activities		149			—			110			—
Total adjustments		5,591			4,156			9,409			8,669
Adjusted EBITDA	$	19,692		$	19,339		$	37,081		$	39,569
Adjusted EBITDA Margin		14.6	%		15.4	%		14.2	%		15.6	%


Proto Labs, Inc.
Comparison of GAAP to Non-GAAP Revenue Growth by Region
(In thousands)
(Unaudited)


	Three Months Ended June 30, 2025							Three Months Ended June 30, 2024		% Change²		% Change Organic³
	GAAP		Foreign Currency¹			Non-GAAP		GAAP		% Change²		% Change Organic³
Revenues
United States	$	110,712	$	—		$	110,712	$	98,541	12.4	%	12.4	%
Europe		24,351		(1,292	)		23,059		27,090	(10.1	)	(14.9	)
Total revenue	$	135,063	$	(1,292	)	$	133,771	$	125,631	7.5	%	6.5	%


	Six Months Ended June 30, 2025							Six Months Ended June 30, 2024		% Change²		% Change Organic³
	GAAP		Foreign Currency¹			Non-GAAP		GAAP		% Change²		% Change Organic³
Revenues
United States	$	210,979	$	—		$	210,979	$	200,022	5.5	%	5.5	%
Europe		50,289		(829	)		49,460		53,499	(6.0	%)	(7.5	%)
Total revenue	$	261,268	$	(829	)	$	260,439	$	253,521	3.1	%	2.7	%

1		Revenue for the three and six months ended June 30, 2025 has been recalculated using 2024 foreign currency exchange rates in effect during comparable periods to provide information useful in evaluating the underlying business trends excluding the impact of changes in foreign currency exchange rates.
2		This column presents the percentage change from GAAP revenue for the three and six months ended June 30, 2024 to GAAP revenue for the three and six months ended June 30, 2025.
3		This column presents the percentage change from GAAP revenue for the three and six months ended June 30, 2024 to non-GAAP revenue for the three and six months ended June 30, 2025 (as recalculated using the foreign currency exchange rates in effect during the three and six months ended June 30, 2024) in order to provide a constant-currency comparison.


Proto Labs, Inc.
Comparison of GAAP to Non-GAAP Revenue Growth by Service Line
(In thousands)
(Unaudited)


	Three Months Ended June 30, 2025							Three Months Ended June 30, 2024		% Change²		% Change Organic³
	GAAP		Foreign Currency¹			Non- GAAP		GAAP		% Change²		% Change Organic³
Revenues
Injection Molding	$	47,415	$	(429	)	$	46,986	$	49,080	(3.4	%)	(4.3	%)
CNC Machining		61,945		(619	)		61,326		51,239	20.9		19.7
3D Printing		21,215		(226	)		20,989		21,281	(0.3	)	(1.4	)
Sheet Metal		4,303		(17	)		4,286		3,922	9.7		9.3
Other Revenue		185		(1	)		184		109	69.7		68.8
Total revenue	$	135,063	$	(1,292	)	$	133,771	$	125,631	7.5	%	6.5	%




	Six Months Ended June 30, 2025							Six Months Ended June 30, 2024		% Change²		% Change Organic³
	GAAP		Foreign Currency¹			Non- GAAP		GAAP		% Change²		% Change Organic³
Revenues
Injection Molding	$	96,138	$	(348	)	$	95,790	$	101,743	(5.5	%)	(5.9	%)
CNC Machining		114,788		(314	)		114,474		101,171	13.5		13.1
3D Printing		41,409		(162	)		41,247		42,863	(3.4	)	(3.8	)
Sheet Metal		8,514		(7	)		8,507		7,475	13.9		13.8
Other Revenue		419		2			421		269	55.8		56.5
Total revenue	$	261,268	$	(829	)	$	260,439	$	253,521	3.1	%	2.7	%

1		Revenue for the three and six months ended June 30, 2025 has been recalculated using 2024 foreign currency exchange rates in effect during comparable periods to provide information useful in evaluating the underlying business trends excluding the impact of changes in foreign currency exchange rates.
2		This column presents the percentage change from GAAP revenue for the three and six months ended June 30, 2024 to GAAP revenue for the three and six months ended June 30, 2025.
3		This column presents the percentage change from GAAP revenue for the three and six months ended June 30, 2024 to non-GAAP revenue for the three and six months ended June 30, 2025 (as recalculated using the foreign currency exchange rates in effect during the three and six months ended June 30, 2024) in order to provide a constant-currency comparison.


Proto Labs, Inc.
Customer Contact Information
(In thousands, except customer contacts and per customer contact amounts)
(Unaudited)


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
Revenue	$	135,063	$	125,631	$	261,268	$	253,521
Customer contacts		21,775		22,456		33,136		34,338
Revenue per customer contact¹	$	6,203	$	5,595	$	7,885	$	7,383

Revenue per customer contact is calculated using the revenue recognized during the respective period divided by the actual number of customer contacts served during the same period. Customer contacts are product developers, engineers, procurement and supply chain professionals and other individuals who place an order, and that order is shipped and invoiced during the period. The Company believes revenue per customer contact is useful to investors in evaluating the underlying business trends and ongoing operating performance of the Company.


Proto Labs, Inc.
Reconciliation of GAAP to Non-GAAP Guidance
(Unaudited)


	Q3 2025 Outlook
	Low		High
GAAP diluted net income per share	$	0.17	$	0.25
Add back:
Stock-based compensation expense		0.15		0.15
Amortization expense		0.03		0.03
Unrealized (gain) loss on foreign currency		0.00		0.00
Total adjustments		0.18		0.18
Non-GAAP diluted net income per share	$	0.35	$	0.43

View source version on businesswire.com: https://www.businesswire.com/news/home/20250731024684/en/

Investor Relations Contacts:

Protolabs

Ryan Johnsrud, 612-225-4873

Manager – Investor Relations and Corporate Development

[email protected]

Gateway Group, Inc.

949-574-3860

[email protected]

Media Contact:

Protolabs

Brent Renneke, 763-479-7704

Marketing Communications Manager

[email protected]

Get the next $PRLB alert in real time by email

Recent Analyst Ratings for

$PRLB

Date	Price Target	Rating	Analyst
8/1/2025	$54.00	Hold → Buy	Craig Hallum
6/5/2024	$44.00	Overweight	Cantor Fitzgerald
8/4/2023		Sell → Hold	Craig Hallum
2/13/2023		Hold → Buy	The Benchmark Company
11/29/2022	$29.00	Buy	Lake Street
11/4/2022		Hold → Sell	Craig Hallum
11/4/2022		Buy → Hold	Craig Hallum
10/29/2021		Buy → Hold	Benchmark

More analyst ratings

Protolabs Reports Financial Results for the Second Quarter of 2025

7/31/25 6:00:00 AM ET

$PRLB

Metal Fabrications

Industrials

Get the next $PRLB alert in real time by email

Record Quarterly Revenue of $135.1 Million, a 7.5% increase Year-Over-Year

GAAP Earnings Per Share of $0.18, Non-GAAP Earnings Per Share of $0.41

Second Quarter 2025 Financial Highlights:

Revenue was a record $135.1 million, a 7.5% increase compared to revenue of $125.6 million in the second quarter of 2024.
Revenue fulfilled through digital factories was $105.8 million, a 4.8% increase year-over-year.
Revenue fulfilled through the Protolabs Network was $29.3 million, an 18.6% increase year-over-year.
Net income was $4.4 million, or $0.18 per diluted share, compared to $4.5 million, or $0.18 per diluted share, in the second quarter of 2024.
Non-GAAP net income was $10.0 million, or $0.41 per diluted share, compared to $9.5 million, or $0.38 per diluted share, in the second quarter of 2024. See "Non-GAAP Financial Measures" below.

Additional Second Quarter 2025 Highlights:

Customer contact information
- Protolabs served 21,775 customer contacts during the quarter.
- Revenue per customer contact increased 10.9% year-over-year to $6,203.
EBITDA was $14.1 million. See "Non-GAAP Financial Measures" below.
Adjusted EBITDA was $19.7 million, or 14.6% of revenue, compared to $19.3 million, or 15.4% of revenue, in the second quarter of 2024. See "Non-GAAP Financial Measures" below.
Cash and investments balance was $123.2 million as of June 30, 2025.

Third Quarter 2025 Outlook

In the third quarter of 2025, the Company expects to generate revenue between $130.0 million and $138.0 million.

Non-GAAP Financial Measures

Conference Call

About Protolabs

Forward-Looking Statements


Proto Labs, Inc.
Condensed Consolidated Balance Sheets
(In thousands)


	June 30, 2025		December 31, 2024
	(Unaudited)
Assets
Current assets
Cash and cash equivalents	$	90,382	$	89,071
Short-term marketable securities		12,804		14,019
Accounts receivable, net		78,011		66,504
Inventory		13,169		12,305
Income taxes receivable		1,155		2,906
Prepaid expenses and other current assets		9,985		10,049
Total current assets		205,506		194,854

Property and equipment, net		215,777		227,263
Goodwill		273,991		273,991
Other intangible assets, net		20,500		21,422
Long-term marketable securities		20,037		17,773
Operating lease assets		2,308		2,993
Finance lease assets		558		692
Other long-term assets		4,575		4,524
Total assets	$	743,252	$	743,512

Liabilities and shareholders' equity
Current liabilities
Accounts payable	$	15,583	$	15,504
Accrued compensation		19,435		16,550
Accrued liabilities and other		25,846		19,621
Current operating lease liabilities		984		1,287
Current finance lease liabilities		316		309
Total current liabilities		62,164		53,271

Long-term operating lease liabilities		1,402		1,633
Long-term finance lease liabilities		127		287
Long-term deferred tax liabilities		9,737		13,565
Other long-term liabilities		5,115		4,605

Shareholders' equity		664,707		670,151
Total liabilities and shareholders' equity	$	743,252	$	743,512


Proto Labs, Inc.
Condensed Consolidated Statements of Operations
(In thousands, except share and per share amounts)
(Unaudited)


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
Revenue
Injection Molding	$	47,415	$	49,080	$	96,138	$	101,743
CNC Machining		61,945		51,239		114,788		101,171
3D Printing		21,215		21,281		41,409		42,863
Sheet Metal		4,303		3,922		8,514		7,475
Other Revenue		185		109		419		269
Total Revenue		135,063		125,631		261,268		253,521

Cost of revenue		75,289		69,085		145,796		139,508
Gross profit		59,774		56,546		115,472		114,013

Operating expenses
Marketing and sales		24,731		23,291		48,480		46,451
Research and development		11,173		10,661		21,782		21,828
General and administrative		18,752		16,595		35,600		32,908
Costs related to exit and disposal activities		149		—		110		—
Total operating expenses		54,805		50,547		105,972		101,187
Income from operations		4,969		5,999		9,500		12,826
Other income, net		1,705		1,361		3,159		2,260
Income before income taxes		6,674		7,360		12,659		15,086
Provision for income taxes		2,247		2,820		4,633		5,278
Net income	$	4,427	$	4,540	$	8,026	$	9,808

Net income per share:
Basic	$	0.19	$	0.18	$	0.33	$	0.39
Diluted	$	0.18	$	0.18	$	0.33	$	0.38

Shares used to compute net income per share:
Basic		23,900,390		25,313,036		24,018,119		25,473,937
Diluted		24,101,592		25,372,972		24,291,246		25,573,344


Proto Labs, Inc.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)


	Six Months Ended June 30,
	2025			2024
Operating activities
Net income	$	8,026		$	9,808
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		17,264			18,075
Stock-based compensation expense		8,251			8,520
Deferred taxes		(3,985	)		(4,144	)
Interest on finance lease obligations		11			18
Impairments related to exit and closure of facilities		448			—
Gain on disposal of property and equipment		—			(20	)
Other		(82	)		64
Changes in operating assets and liabilities		(970	)		3,460
Net cash provided by operating activities		28,963			35,781

Investing activities
Purchases of property, equipment and other capital assets		(2,730	)		(6,784	)
Proceeds from sales of property, equipment and other capital assets		—			30
Purchases of marketable securities		(11,052	)		—
Proceeds from call redemptions and maturities of marketable securities		10,230			10,419
Net cash (used in) provided by investing activities		(3,552	)		3,665

Financing activities
Proceeds from issuance of common stock from equity plans		2,081			2,094
Purchases of shares withheld for tax obligations		(3,117	)		(1,920	)
Repurchases of common stock		(23,980	)		(26,940	)
Principal repayments of finance lease obligations		(153	)		(146	)
Net cash used in financing activities		(25,169	)		(26,912	)
Effect of exchange rate changes on cash and cash equivalents		1,069			(175	)
Net increase in cash and cash equivalents		1,311			12,359
Cash and cash equivalents, beginning of period		89,071			83,790
Cash and cash equivalents, end of period	$	90,382		$	96,149


Proto Labs, Inc.
Reconciliation of GAAP to Non-GAAP Net Income and Non-GAAP Net Income per Share
(In thousands, except share and per share amounts)
(Unaudited)


	Three Months Ended June 30,						Six Months Ended June 30,
	2025			2024			2025			2024
Non-GAAP net income, adjusted for stock-based compensation expense, amortization expense, unrealized (gain) loss on foreign currency, CEO transition costs and costs related to exit and disposal activities
GAAP net income	$	4,427		$	4,540		$	8,026		$	9,808
Add back:
Stock-based compensation expense		4,259			4,244			8,251			8,520
Amortization expense		927			921			1,835			1,908
Unrealized (gain) loss on foreign currency		(179	)		(88	)		(314	)		149
CEO transition costs		1,362			—			1,362			—
Costs related to exit and disposal activities		149			—			110			—
Total adjustments ¹		6,518			5,077			11,244			10,577
Income tax benefits on adjustments ²		(958	)		(85	)		(1,200	)		(439	)
Non-GAAP net income	$	9,987		$	9,532		$	18,070		$	19,946


Non-GAAP net income per share:
Basic	$	0.42		$	0.38		$	0.75		$	0.78
Diluted	$	0.41		$	0.38		$	0.74		$	0.78

Shares used to compute non-GAAP net income per share:
Basic		23,900,390			25,313,036			24,018,119			25,473,937
Diluted		24,101,592			25,372,972			24,291,246			25,573,344

	Three Months Ended June 30,						Six Months Ended June 30,
	2025			2024			2025			2024

Cost of revenue	$	767		$	810		$	1,569		$	1,611

Marketing and sales		808			819			1,586			1,652
Research and development		735			667			1,360			1,359
General and administrative		4,238			2,869			6,933			5,806
Costs related to exit and disposal activities		149			—			110			—
Total operating expenses		5,930			4,355			9,989			8,817

Other income, net		(179	)		(88	)		(314	)		149
Total adjustments	$	6,518		$	5,077		$	11,244		$	10,577


Proto Labs, Inc.
Reconciliation of GAAP to Non-GAAP Gross Margin
(In thousands)
(Unaudited)


	Three Months Ended June 30,						Six Months Ended June 30,
	2025			2024			2025			2024
Revenue	$	135,063		$	125,631		$	261,268		$	253,521
Gross profit		59,774			56,546			115,472			114,013
GAAP gross margin		44.3	%		45.0	%		44.2	%		45.0	%
Add back:
Stock-based compensation expense		424			468			884			927
Amortization expense		343			342			685			684
Total adjustments		767			810			1,569			1,611
Non-GAAP gross profit	$	60,541		$	57,356		$	117,041		$	115,624
Non-GAAP gross margin		44.8	%		45.7	%		44.8	%		45.6	%


Proto Labs, Inc.
Reconciliation of GAAP to Non-GAAP Operating Margin
(In thousands)
(Unaudited)


	Three Months Ended June 30,						Six Months Ended June 30,
	2025			2024			2025			2024
Revenue	$	135,063		$	125,631		$	261,268		$	253,521
Income from operations		4,969			5,999			9,500			12,826
GAAP operating margin		3.7	%		4.8	%		3.6	%		5.1	%
Add back:
Stock-based compensation expense		4,259			4,244			8,251			8,520
Amortization expense		927			921			1,835			1,908
CEO transition costs		1,362			—			1,362			—
Costs related to exit and disposal activities		149			—			110			—
Total adjustments		6,697			5,165			11,558			10,428
Non-GAAP income from operations	$	11,666		$	11,164		$	21,058		$	23,254
Non-GAAP operating margin		8.6	%		8.9	%		8.1	%		9.2	%


Proto Labs, Inc.
Reconciliation of GAAP Net Income to EBITDA and Adjusted EBITDA
(In thousands)
(Unaudited)


	Three Months Ended June 30,						Six Months Ended June 30,
	2025			2024			2025			2024
Revenue	$	135,063		$	125,631		$	261,268		$	253,521
GAAP net income		4,427			4,540			8,026			9,808
GAAP net income margin		3.3	%		3.6	%		3.1	%		3.9	%
Add back:
Amortization expense	$	927		$	921		$	1,835		$	1,908
Depreciation expense		7,643			8,051			15,429			16,167
Interest income, net		(1,143	)		(1,149	)		(2,251	)		(2,261	)
Provision for income taxes		2,247			2,820			4,633			5,278
EBITDA		14,101			15,183			27,672			30,900
EBITDA Margin		10.4	%		12.1	%		10.6	%		12.2	%
Add back:
Stock-based compensation expense		4,259			4,244			8,251			8,520
Unrealized (gain) loss on foreign currency		(179	)		(88	)		(314	)		149
CEO transition costs		1,362			—			1,362			—
Costs related to exit and disposal activities		149			—			110			—
Total adjustments		5,591			4,156			9,409			8,669
Adjusted EBITDA	$	19,692		$	19,339		$	37,081		$	39,569
Adjusted EBITDA Margin		14.6	%		15.4	%		14.2	%		15.6	%


Proto Labs, Inc.
Comparison of GAAP to Non-GAAP Revenue Growth by Region
(In thousands)
(Unaudited)


	Three Months Ended June 30, 2025							Three Months Ended June 30, 2024		% Change²		% Change Organic³
	GAAP		Foreign Currency¹			Non-GAAP		GAAP		% Change²		% Change Organic³
Revenues
United States	$	110,712	$	—		$	110,712	$	98,541	12.4	%	12.4	%
Europe		24,351		(1,292	)		23,059		27,090	(10.1	)	(14.9	)
Total revenue	$	135,063	$	(1,292	)	$	133,771	$	125,631	7.5	%	6.5	%


	Six Months Ended June 30, 2025							Six Months Ended June 30, 2024		% Change²		% Change Organic³
	GAAP		Foreign Currency¹			Non-GAAP		GAAP		% Change²		% Change Organic³
Revenues
United States	$	210,979	$	—		$	210,979	$	200,022	5.5	%	5.5	%
Europe		50,289		(829	)		49,460		53,499	(6.0	%)	(7.5	%)
Total revenue	$	261,268	$	(829	)	$	260,439	$	253,521	3.1	%	2.7	%

1		Revenue for the three and six months ended June 30, 2025 has been recalculated using 2024 foreign currency exchange rates in effect during comparable periods to provide information useful in evaluating the underlying business trends excluding the impact of changes in foreign currency exchange rates.
2		This column presents the percentage change from GAAP revenue for the three and six months ended June 30, 2024 to GAAP revenue for the three and six months ended June 30, 2025.
3		This column presents the percentage change from GAAP revenue for the three and six months ended June 30, 2024 to non-GAAP revenue for the three and six months ended June 30, 2025 (as recalculated using the foreign currency exchange rates in effect during the three and six months ended June 30, 2024) in order to provide a constant-currency comparison.


Proto Labs, Inc.
Comparison of GAAP to Non-GAAP Revenue Growth by Service Line
(In thousands)
(Unaudited)


	Three Months Ended June 30, 2025							Three Months Ended June 30, 2024		% Change²		% Change Organic³
	GAAP		Foreign Currency¹			Non- GAAP		GAAP		% Change²		% Change Organic³
Revenues
Injection Molding	$	47,415	$	(429	)	$	46,986	$	49,080	(3.4	%)	(4.3	%)
CNC Machining		61,945		(619	)		61,326		51,239	20.9		19.7
3D Printing		21,215		(226	)		20,989		21,281	(0.3	)	(1.4	)
Sheet Metal		4,303		(17	)		4,286		3,922	9.7		9.3
Other Revenue		185		(1	)		184		109	69.7		68.8
Total revenue	$	135,063	$	(1,292	)	$	133,771	$	125,631	7.5	%	6.5	%




	Six Months Ended June 30, 2025							Six Months Ended June 30, 2024		% Change²		% Change Organic³
	GAAP		Foreign Currency¹			Non- GAAP		GAAP		% Change²		% Change Organic³
Revenues
Injection Molding	$	96,138	$	(348	)	$	95,790	$	101,743	(5.5	%)	(5.9	%)
CNC Machining		114,788		(314	)		114,474		101,171	13.5		13.1
3D Printing		41,409		(162	)		41,247		42,863	(3.4	)	(3.8	)
Sheet Metal		8,514		(7	)		8,507		7,475	13.9		13.8
Other Revenue		419		2			421		269	55.8		56.5
Total revenue	$	261,268	$	(829	)	$	260,439	$	253,521	3.1	%	2.7	%

1		Revenue for the three and six months ended June 30, 2025 has been recalculated using 2024 foreign currency exchange rates in effect during comparable periods to provide information useful in evaluating the underlying business trends excluding the impact of changes in foreign currency exchange rates.
2		This column presents the percentage change from GAAP revenue for the three and six months ended June 30, 2024 to GAAP revenue for the three and six months ended June 30, 2025.
3		This column presents the percentage change from GAAP revenue for the three and six months ended June 30, 2024 to non-GAAP revenue for the three and six months ended June 30, 2025 (as recalculated using the foreign currency exchange rates in effect during the three and six months ended June 30, 2024) in order to provide a constant-currency comparison.


Proto Labs, Inc.
Customer Contact Information
(In thousands, except customer contacts and per customer contact amounts)
(Unaudited)


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
Revenue	$	135,063	$	125,631	$	261,268	$	253,521
Customer contacts		21,775		22,456		33,136		34,338
Revenue per customer contact¹	$	6,203	$	5,595	$	7,885	$	7,383


Proto Labs, Inc.
Reconciliation of GAAP to Non-GAAP Guidance
(Unaudited)


	Q3 2025 Outlook
	Low		High
GAAP diluted net income per share	$	0.17	$	0.25
Add back:
Stock-based compensation expense		0.15		0.15
Amortization expense		0.03		0.03
Unrealized (gain) loss on foreign currency		0.00		0.00
Total adjustments		0.18		0.18
Non-GAAP diluted net income per share	$	0.35	$	0.43

View source version on businesswire.com: https://www.businesswire.com/news/home/20250731024684/en/

Investor Relations Contacts:

Protolabs

Ryan Johnsrud, 612-225-4873

Manager – Investor Relations and Corporate Development

[email protected]

Gateway Group, Inc.

949-574-3860

[email protected]

Media Contact:

Protolabs

Brent Renneke, 763-479-7704

Marketing Communications Manager

[email protected]

Get the next $PRLB alert in real time by email

Recent Analyst Ratings for

$PRLB

Date	Price Target	Rating	Analyst
8/1/2025	$54.00	Hold → Buy	Craig Hallum
6/5/2024	$44.00	Overweight	Cantor Fitzgerald
8/4/2023		Sell → Hold	Craig Hallum
2/13/2023		Hold → Buy	The Benchmark Company
11/29/2022	$29.00	Buy	Lake Street
11/4/2022		Hold → Sell	Craig Hallum
11/4/2022		Buy → Hold	Craig Hallum
10/29/2021		Buy → Hold	Benchmark

More analyst ratings

Protolabs Reports Financial Results for the Second Quarter of 2025

Crush Q3 2025 with the Best AI Superconnector

Recent Analyst Ratings for
$PRLB

Protolabs Reports Financial Results for the Second Quarter of 2025

Crush Q3 2025 with the Best AI Superconnector

Recent Analyst Ratings for
$PRLB

$PRLB
Insider Trading

Director Gawlick Rainer bought $75,105 worth of shares (1,715 units at $43.79), increasing direct ownership by 4% to 43,883 units (SEC Form 4)

President and CEO Krishna Suresh bought $75,055 worth of shares (1,725 units at $43.51), increasing direct ownership by 11% to 18,021 units (SEC Form 4)

Director Black Archie C. was granted 3,939 shares, increasing direct ownership by 18% to 26,218 units (SEC Form 4)

$PRLB
Press Releases